MEDICAL PROPERTIES TRUST INC (MPW) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:MPW - US58463J3041 - REIT
5.14 USD
+0.06 (+1.18%)
5.14 USD
0 (0%)
Overall MPW gets a fundamental rating of 3 out of 10. We evaluated MPW against 128 industry peers in the Diversified REITs industry. There are concerns on the financial health of MPW while its profitability can be described as average. MPW is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year MPW has reported negative net income.
MPW had a positive operating cash flow in the past year.
In multiple years MPW reported negative net income over the last 5 years.
MPW had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -4.74%, MPW is doing worse than 82.03% of the companies in the same industry.
Looking at the Return On Equity, with a value of -15.19%, MPW is doing worse than 78.13% of the companies in the same industry.
The Return On Invested Capital of MPW (2.76%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for MPW is in line with the industry average of 3.05%.
The 3 year average ROIC (2.26%) for MPW is below the current ROIC(2.76%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.74% | ||
| ROE | -15.19% | ||
| ROIC | 2.76% |
ROA(3y)-5.11%
ROA(5y)-1.92%
ROE(3y)-15.57%
ROE(5y)-6.62%
ROIC(3y)2.26%
ROIC(5y)2.99%
1.3 Margins
The Operating Margin of MPW (53.48%) is better than 95.31% of its industry peers.
In the last couple of years the Operating Margin of MPW has declined.
MPW has a Gross Margin of 96.07%. This is amongst the best in the industry. MPW outperforms 97.66% of its industry peers.
In the last couple of years the Gross Margin of MPW has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 53.48% | ||
| PM (TTM) | N/A | ||
| GM | 96.07% |
OM growth 3Y-16.71%
OM growth 5Y-10.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.03%
GM growth 5Y-0.02%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MPW is destroying value.
MPW has more shares outstanding than it did 1 year ago.
The number of shares outstanding for MPW has been increased compared to 5 years ago.
MPW has a worse debt/assets ratio than last year.
2.2 Solvency
MPW has an Altman-Z score of 0.02. This is a bad value and indicates that MPW is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.02, MPW is not doing good in the industry: 74.22% of the companies in the same industry are doing better.
A Debt/Equity ratio of 2.06 is on the high side and indicates that MPW has dependencies on debt financing.
With a Debt to Equity ratio value of 2.06, MPW is not doing good in the industry: 71.09% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.06 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.02 |
ROIC/WACC0.45
WACC6.12%
2.3 Liquidity
MPW has a Current Ratio of 2.00. This is a normal value and indicates that MPW is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Current ratio value of 2.00, MPW belongs to the best of the industry, outperforming 80.47% of the companies in the same industry.
MPW has a Quick Ratio of 2.00. This is a normal value and indicates that MPW is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of MPW (2.00) is better than 80.47% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2 | ||
| Quick Ratio | 2 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 43.50% over the past year.
Looking at the last year, MPW shows a very strong growth in Revenue. The Revenue has grown by 45.56%.
The Revenue has been growing slightly by 3.11% on average over the past years.
EPS 1Y (TTM)43.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90.3%
Revenue 1Y (TTM)45.56%
Revenue growth 3Y-13.62%
Revenue growth 5Y3.11%
Sales Q2Q%5.18%
3.2 Future
Based on estimates for the next years, MPW will show a very strong growth in Earnings Per Share. The EPS will grow by 27.74% on average per year.
MPW is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.08% yearly.
EPS Next Y88.91%
EPS Next 2Y43.28%
EPS Next 3Y27.74%
EPS Next 5YN/A
Revenue Next Year-4.1%
Revenue Next 2Y1.94%
Revenue Next 3Y3.68%
Revenue Next 5Y2.08%
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for MPW. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 36.88 indicates a quite expensive valuation of MPW.
MPW's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. MPW is cheaper than 68.75% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.83, MPW is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 36.88 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MPW is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 15.97 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MPW's earnings are expected to grow with 27.74% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y43.28%
EPS Next 3Y27.74%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 7.09%, MPW is a good candidate for dividend investing.
MPW's Dividend Yield is a higher than the industry average which is at 6.20.
MPW's Dividend Yield is rather good when compared to the S&P500 average which is at 1.87.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.09% |
5.2 History
The dividend of MPW decreases each year by -10.38%.
MPW has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-10.38%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
MPW has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-27.26%
EPS Next 2Y43.28%
EPS Next 3Y27.74%
5.14
+0.06 (+1.18%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners57.6%
Inst Owner Change-3.04%
Ins Owners17.26%
Ins Owner Change-2.04%
Market Cap3.09B
Revenue(TTM)933.52M
Net Income(TTM)-707.95M
Analysts51.76
Price Target5.25 (2.14%)
Short Float %30.7%
Short Ratio20.46
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.09% |
Yearly Dividend0.54
Dividend Growth(5Y)-10.38%
DP-27.26%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-873.24%
Min EPS beat(2)-1816.17%
Max EPS beat(2)69.68%
EPS beat(4)1
Avg EPS beat(4)-3643.79%
Min EPS beat(4)-11757.5%
Max EPS beat(4)69.68%
EPS beat(8)2
Avg EPS beat(8)-2173.83%
EPS beat(12)2
Avg EPS beat(12)-1482.28%
EPS beat(16)6
Avg EPS beat(16)-1094.33%
Revenue beat(2)2
Avg Revenue beat(2)1.43%
Min Revenue beat(2)0.7%
Max Revenue beat(2)2.15%
Revenue beat(4)3
Avg Revenue beat(4)1.19%
Min Revenue beat(4)-3.58%
Max Revenue beat(4)5.51%
Revenue beat(8)5
Avg Revenue beat(8)0.69%
Revenue beat(12)6
Avg Revenue beat(12)-0.69%
Revenue beat(16)7
Avg Revenue beat(16)-1.26%
PT rev (1m)5.88%
PT rev (3m)5.88%
EPS NQ rev (1m)-25%
EPS NQ rev (3m)-43.76%
EPS NY rev (1m)-12.62%
EPS NY rev (3m)-271.79%
Revenue NQ rev (1m)0.84%
Revenue NQ rev (3m)0.63%
Revenue NY rev (1m)0.82%
Revenue NY rev (3m)-0.27%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 36.88 | ||
| P/S | 3.31 | ||
| P/FCF | N/A | ||
| P/OCF | 20.98 | ||
| P/B | 0.66 | ||
| P/tB | 0.66 | ||
| EV/EBITDA | 15.97 |
EPS(TTM)-1
EYN/A
EPS(NY)0.14
Fwd EY2.71%
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.25
OCFY4.77%
SpS1.55
BVpS7.75
TBVpS7.75
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.74% | ||
| ROE | -15.19% | ||
| ROCE | 3.49% | ||
| ROIC | 2.76% | ||
| ROICexc | 2.84% | ||
| ROICexgc | 2.95% | ||
| OM | 53.48% | ||
| PM (TTM) | N/A | ||
| GM | 96.07% | ||
| FCFM | N/A |
ROA(3y)-5.11%
ROA(5y)-1.92%
ROE(3y)-15.57%
ROE(5y)-6.62%
ROIC(3y)2.26%
ROIC(5y)2.99%
ROICexc(3y)2.3%
ROICexc(5y)3.06%
ROICexgc(3y)2.37%
ROICexgc(5y)3.14%
ROCE(3y)2.86%
ROCE(5y)3.79%
ROICexgc growth 3Y-18.25%
ROICexgc growth 5Y-8.72%
ROICexc growth 3Y-18.71%
ROICexc growth 5Y-8.92%
OM growth 3Y-16.71%
OM growth 5Y-10.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.03%
GM growth 5Y-0.02%
F-Score5
Asset Turnover0.06
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.06 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 12.51 | ||
| Cap/Depr | 69.46% | ||
| Cap/Sales | 20.04% | ||
| Interest Coverage | 1.08 | ||
| Cash Conversion | 19.18% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2 | ||
| Quick Ratio | 2 | ||
| Altman-Z | 0.02 |
F-Score5
WACC6.12%
ROIC/WACC0.45
Cap/Depr(3y)171.64%
Cap/Depr(5y)740.47%
Cap/Sales(3y)50.73%
Cap/Sales(5y)169.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)43.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90.3%
EPS Next Y88.91%
EPS Next 2Y43.28%
EPS Next 3Y27.74%
EPS Next 5YN/A
Revenue 1Y (TTM)45.56%
Revenue growth 3Y-13.62%
Revenue growth 5Y3.11%
Sales Q2Q%5.18%
Revenue Next Year-4.1%
Revenue Next 2Y1.94%
Revenue Next 3Y3.68%
Revenue Next 5Y2.08%
EBIT growth 1Y1889.1%
EBIT growth 3Y-28.05%
EBIT growth 5Y-7.83%
EBIT Next Year125.57%
EBIT Next 3Y37.79%
EBIT Next 5Y20.09%
FCF growth 1Y70.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-73.27%
OCF growth 3Y-32.88%
OCF growth 5Y-13.06%
MEDICAL PROPERTIES TRUST INC / MPW FAQ
What is the fundamental rating for MPW stock?
ChartMill assigns a fundamental rating of 3 / 10 to MPW.
What is the valuation status for MPW stock?
ChartMill assigns a valuation rating of 2 / 10 to MEDICAL PROPERTIES TRUST INC (MPW). This can be considered as Overvalued.
Can you provide the profitability details for MEDICAL PROPERTIES TRUST INC?
MEDICAL PROPERTIES TRUST INC (MPW) has a profitability rating of 4 / 10.
What is the financial health of MEDICAL PROPERTIES TRUST INC (MPW) stock?
The financial health rating of MEDICAL PROPERTIES TRUST INC (MPW) is 2 / 10.
Can you provide the expected EPS growth for MPW stock?
The Earnings per Share (EPS) of MEDICAL PROPERTIES TRUST INC (MPW) is expected to grow by 88.91% in the next year.